GlassScriptPhysician profile
Benjamin Yim
NPI 1598176604
$125,831.83
in general payments reported to CMS, 2019-2025
25 companies · $95K in 2025
The $95K reported for 2025 was more than what 97% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,776 · 2020: $794 · 2021: $741 · 2022: $2,864 · 2023: $6,135 · 2024: $19K · 2025: $95K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $54K · Travel and Lodging: $39K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Food and Beverage: $6,626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $53,822.37 |
| Travel and Lodging | $38,708.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,500.00 |
| Food and Beverage | $6,626.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rapid Medical LTD | $34,224.84 | 2023-2025 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Qapel Medical INC | $23,301.30 | 2023-2025 | |
| Penumbra, INC. | $17,973.19 | 2022-2025 | Indigo System, Penumbra System, Smart Coil |
| Stryker Corporation | $15,163.27 | 2019-2025 | Surpass Evolve, Tgs, Target |
| Microvention, INC. | $15,134.34 | 2019-2025 | Web Aneurysm Embolization System, Stent, Sofia 6f-131cm Str |
| Medical Device Business Services, INC. | $9,758.78 | 2025 | Spotlight |
| Imperative Care, INC | $4,568.55 | 2022-2025 | Zoom 88-T Large Distal Platform, Zoom Rdl Radial Access System, 103cm, Zoom Reperfusion Catheter |
| Kaneka Medical America LLC | $2,696.22 | 2025 | Apheresis Machine |
| Medtronic, INC. | $1,007.40 | 2021-2024 | Anteralign Spinal System With Titan Nanolock Surface Technology, Pipeline, Cd Horizon Spinal System |
| Depuy Synthes Sales INC. | $611.12 | 2019-2022 | |
| Medtronic USA, INC. | $337.21 | 2019-2020 | |
| Nuvasive, INC. | $156.65 | 2020 | |
| Balt USA, LLC | $148.96 | 2023 | |
| Viz.Ai, INC. | $132.18 | 2022 | |
| Radius Health, INC. | $120.06 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $113.51 | 2019 | |
| Augmedics INC. | $86.20 | 2020 | |
| Abbott Laboratories | $81.28 | 2023-2025 | Perclose Prostyle |
| Aesculap, INC. | $51.46 | 2022 | |
| Microtransponder, INC. | $41.50 | 2025 | |
| Zimmer Biomet Holdings, INC. | $32.56 | 2020-2021 | |
| Vertos Medical, INC. | $27.92 | 2023 | Mild Device Kit |
| Siemens Medical Solutions USA, INC. | $24.10 | 2024 | Artis Icono Biplane |
| Zimvie INC. | $19.90 | 2022 | |
| Monteris Medical Corporation | $19.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Yim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.